greeksoup/ stock research
Stock research / United States / AZN / Year to 31 December 2021

AstraZeneca PLC (AZN) annual results, year to 31 December 2021: revenue USD 37,417 million, from the 20-F

AstraZeneca PLC files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2021 it reported revenue of USD 37,417 million, up 40.6% on the year before. Its profit attributable to shareholders was USD 112 million, down 96.5%, and diluted earnings per share USD 0.08.

Revenue
USD 37,417 million
+40.6% on the year
FY2015FY2021
Operating margin
2.8%
19.4% a year earlier
FY2015FY2021
Net income
USD 112 million
-96.5% on the year
FY2015FY2021
Diluted EPS
USD 0.08
-96.7% on the year
FY2015FY2021

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2020Dec 2021
Revenue26,61737,417
Cost of sales5,29912,437
Gross profit21,31824,980
Research and development5,9919,736
Selling, general and administrative11,29415,234
Operating profit5,1621,056
Finance costs1,3061,300
Profit before tax3,916-265
Income tax772-380
Profit for the year3,144115
Profit attributable to shareholders3,196112
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2020Dec 2021
Diluted EPS2.440.08
Basic EPS2.440.08
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2020Dec 2021
Cash from operations4,7995,963
Purchase of property, plant and equipment9611,091
Free cash flow3,8384,872
Cash from investing-285-11,058
Cash from financing-2,2033,649
Buybacksn/a149
Dividends paid3,5723,856
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2020Dec 2021
Funded by
Equity attributable to shareholders15,62239,268
Non-controlling interests16.019.0
Borrowings, as filed19,69929,794
Lease liabilities681987
Other liabilities30,71135,295
Total equity and liabilities66,729105,363
Owned
Property, plant and equipment8,2519,183
Goodwill11,84519,997
Other intangible assets20,94742,492
Cash and cash equivalents7,8326,329
Trade and other receivables7,0229,644
Inventories4,0248,983
Other assets6,8088,735
Total assets66,729105,363
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2020Dec 2021
Gross margin80.1%66.8%
Operating margin19.4%2.8%
Net margin12.0%0.3%
Free cash flow margin14.4%13.0%
Return on year-end equity20.5%0.3%
Effective tax rate19.7%n/a
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2021, filed 20 February 2024: the filing. The figures are in US dollars as filed.